EP4094766
ORAL FIXED DOSE COMBINATION AND USE THEREOF IN THE TREATMENT OF UTERINE FIBROIDS AND ENDOMETRIOSIS
:
EP einkaleyfi: Þýðing ekki lögð inn:
29.9.2017:
2.4.2025:
22162349.9
:
28.9.2037
:
ORAL FIXED DOSE COMBINATION AND USE THEREOF IN THE TREATMENT OF UTERINE FIBROIDS AND ENDOMETRIOSIS
29.9.2017
2.4.2025
:
Sumitomo Pharma Switzerland GmbH:
Aeschengraben 27 Floor 22, 4051 Basel, CH
:
Takeda Pharmaceutical Company Limited:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi,, Osaka 541-0045, JP
:
JOHNSON, Brendan Mark:
Chapel Hill, North Carolina 27514, US
:
SEELY, Lynn:
San Mateo, California 94402, US
:
MUDD, Paul N. Jr.:
Cary, North Carolina 27519, US
:
WOLLOWITZ, Susan:
Lafayette, California 94549, US
:
HIBBERD, Mark:
Hampshire, GU33 6NQ, GB
:
TANIMOTO, Masataka:
Osaka-shi 540-8645, JP
:
RAJASEKHAR, Vijaykumar Reddy:
Apple Valley, California 92308, US
:
SUKHATME, Mayukh Vasant:
New York 10018, US
:
201662402034 P:
30.9.2016:
US
:
201662402055 P:
30.9.2016:
US
:
201662402150 P:
30.9.2016:
US
:
201762492839 P:
1.5.2017:
US
:
201762528409 P:
3.7.2017:
US
:
A61K 31/513, A61K 31/565, A61K 31/57, A61P 15/00